Nitisha Pyndiah, PhD, is a Consultant for HartmannWillner where she provides Biologics Consulting Services to clients in the biopharmaceutical industry. Her expertise encompasses strategic support for the development of biological, biotechnological, and biosimilar products during preclinical development and throughout the product lifecycle.

Nitisha has over eight years of experience in biomedical research, biotechnology, clinical studies and biologics consulting services. Her biologics consulting expertise includes new technologies, virology, molecular biology, immunology (including immunogenicity), quality control, quality assurance, audits, Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). With her scientific background and experience working on a range of products for the pharmaceutical industry, Nitisha aims to help clients mitigate the patient’s risk to developing an undesirable immune reaction to the therapeutic product.